NEW YORK -- (BUSINESS WIRE) -- Precision Dermatology Inc., a specialty pharmaceutical company focused in dermatology announced today that Robert J. Moccia has been appointed to the position of Chief Executive Officer. Mr. Moccia has lead the introduction of a number of new strategies for growth since joining the company in January of this year. The company is experiencing strong organic growth and has a number of initiatives in place that will continue to strengthen its position in the dermatology market place.
Mr. Moccia has 30 years of experience in dermatology. He most recently served as COO of Precision and President of Onset Dermatologics Inc. headquartered in Cumberland, Rhode Island. He will remain President of Onset and will be made a member of the Board of Directors. Previously, he led Graceway Pharmaceuticals as its President and COO from its establishment in 2007 until its acquisition by Medicis Pharmaceuticals in 2011. Under his leadership, the company marketed the leading drug for the treatment of actinic keratosis and developed a robust pipeline of prescription dermatologic therapies. Formerly, Mr. Moccia was CEO and President of Chester Valley Pharmaceuticals, a company he co-founded, and President of Bioglan Pharmaceuticals. Through his career, Mr. Moccia also had held key positions at Medicis Pharmaceuticals and Dermik Laboratories. Mr. Moccia is an expert in creating customer-focused organizations that are widely admired for operational excellence and quality. Mr. Moccia holds a B.S. degree from Stonehill College.
William W. Crouse, Chairman of the Board of Directors at Precision Dermatology commented, “Bob has done an excellent job positioning the company for long term growth and have set a goal of becoming a top dermatology company in the US. This is a well-deserved promotion and the Board of Directors look forward to his continued leadership of the company.”
About Precision Dermatology, Inc.
Headquartered in New York, New York and Cumberland, Rhode Island, Precision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to physicians and patients that demonstrably improve the skin. Precision Dermatology is rapidly expanding through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities. For additional information, please visit www.precisionderm.com